243 related articles for article (PubMed ID: 20559006)
1. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study.
Bousquet J; Bachert C; Canonica GW; Mullol J; Van Cauwenberge P; Jensen CB; Fokkens WJ; Ring J; Keith P; Gopalan G; Lorber R; Zuberbier T;
Int Arch Allergy Immunol; 2010; 153(4):395-402. PubMed ID: 20559006
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.
Bousquet J; Bachert C; Canonica GW; Mullol J; Van Cauwenberge P; Bindslev Jensen C; Fokkens WJ; Ring J; Keith P; Lorber R; Zuberbier T;
Allergy; 2009 Oct; 64(10):1516-1523. PubMed ID: 19624554
[TBL] [Abstract][Full Text] [Related]
3. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
Bachert C; van Cauwenberge P
Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
Grubbe RE; Lumry WR; Anolik R
J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
Berger WE; Schenkel EJ; Mansfield LE;
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis.
Sullivan PW; Navaratnam P; Lorber R; Shekar T
Curr Med Res Opin; 2010 Jun; 26(6):1389-97. PubMed ID: 20384438
[TBL] [Abstract][Full Text] [Related]
9. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
[TBL] [Abstract][Full Text] [Related]
10. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis.
Holmberg K; Tonnel AB; Dreyfus I; Olsson P; Cougnard J; Mesbah K; Devillier P
Allergy; 2009 Nov; 64(11):1663-70. PubMed ID: 19740126
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
12. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
13. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
Pradalier A; Neukirch C; Dreyfus I; Devillier P
Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
Raphael GD; Angello JT; Wu MM; Druce HM
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
[TBL] [Abstract][Full Text] [Related]
15. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
18. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139].
Salmun LM; Lorber R
BMC Fam Pract; 2002 Aug; 3():14. PubMed ID: 12162793
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.
Simons FE; Prenner BM; Finn A;
J Allergy Clin Immunol; 2003 Mar; 111(3):617-22. PubMed ID: 12642846
[TBL] [Abstract][Full Text] [Related]
20. Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Potter P; Maspero JF; Vermeulen J; Barkai L; Németh I; Baillieau RA; Garde JM; Giralt J; Doménech A; Izquierdo I; Nieto A
Pediatr Allergy Immunol; 2013 Mar; 24(2):144-50. PubMed ID: 23384091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
